Tech vs. cancer The race to make the disease obsolete
Cancer is a terrifying diagnosis. The second-leading cause of death in the United States drains $25 trillion a year from the ...
TMCnet15 小时
Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World's ...
Colossal Biosciences, the world's first de-extinction company, has today announced $200M in a Series C financing by TWG ...
The Debrief16 小时
Colossal Secures $200M, Advancing De-Extinction Science That Soon Could Resurrect the Wooly ...
Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new milestone.
PharmiWeb18 小时
Touchlight’s dbDNA™ Manufacturing Facility Receives World-First GMP License from MHRA
Touchlight, an innovation-driven Contract Development and Manufacturing Organisation (CDMO), today announced that its facility in Hampton UK has received GMP certification. As a result, Touchlight ...